Defining the clinical course of multiple sclerosis

Fred Lublin(Icahn School of Medicine at Mount Sinai), Chris H. Polman(Vrije Universiteit Amsterdam), Robert J. Fox(Cleveland Clinic), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Bruce F. Bebo(National Multiple Sclerosis Society), Olaf Stüve(Southwestern Medical Center), Emmanuelle Waubant(University of California, San Francisco), Gary Cutter(Alabama Department of Public Health), John A. Lincoln(The University of Texas Health Science Center), Stephen C. Reingold(Clinical Research Associates), Andrew Goodman, Catherine Lubetzki(Centre National de la Recherche Scientifique), Ludwig Kappos(Novartis (Switzerland)), Peter A. Calabresi(Johns Hopkins University), Maria Pia Sormani(University of Genoa), Matilde Inglese(New York University), Frederik Barkhof(Netherlands Institute for Neuroscience), Alan J. Thompson(Queen Mary University of London), Richard A. Rudick(Icahn School of Medicine at Mount Sinai), Per Soelberg Sørensen(University of Copenhagen), Jerry S. Wolinsky(The University of Texas Health Science Center at Houston), Brenda Banwell(University of Toronto), John Petkau(National Multiple Sclerosis Society), Carlo Pozzilli(Ophthalmology Clinic), Paul O’Connor, Jeffrey A. Cohen(Cleveland Clinic), Mark S. Freedman, Aaron E. Miller(Icahn School of Medicine at Mount Sinai), Bernd C. Kieseier(Heinrich Heine University Düsseldorf), Laura J. Balcer(University of Pennsylvania), Giancarlo Comi(Vita-Salute San Raffaele University), Michel Clanet(National Multiple Sclerosis Society)
Neurology
May 28, 2014
Cited by 3,144


Related Papers